Trial intelligence / Profile preview

Topical Doxepin for Radiation-induced Dermatitis

NCT02447211Phase 2Unknown

Start
May 2015
Primary completion
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of doxepin in radiation dermatitis. Status: unknown.

02

Drugs

doxepin
03

Conditions

radiation dermatitis

Beyond the preview

Go deeper on NCT02447211.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02447211.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call